Approval · Notice of Compliance 17127 · 2015
CYRAMZA: Notice of Compliance 17127
Issued July 16, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17127
- Date
- July 16, 2015
- Company
- Eli Lilly Canada IncToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antineoplastic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CYRAMZA | 02443805 | Marketed |
Medicinal ingredients
- RAMUCIRUMAB 10 MG per ML